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Abstract
Background: The implementation of maternal health guidelines remains
unsatisfactory, even for simple, well established interventions. In settings where
most births occur in health facilities, as is the case in Kerala, India, preventing
maternal mortality is linked to quality of care improvements.
Context: Evidence-informed quality standards (QS), including quality
statements and measurable structure and process indicators, are one
innovative way of tackling the guideline implementation gap. Having adopted a
zero tolerance policy to maternal deaths, the Government of Kerala worked in
partnership with the Kerala Federation of Obstetricians & Gynaecologists
(KFOG) and NICE International to select the clinical topic, develop and initiate
implementation of the first clinical QS for reducing maternal mortality in the
state.
Description of practice: The NICE QS development framework was adapted to
the Kerala context, with local ownership being a key principle. Locally
generated evidence identified post-partum haemorrhage as the leading cause
of maternal death, and as the key priority for the QS. A multidisciplinary group
(including policy-makers, gynaecologists and obstetricians, nurses and
administrators) was established. Multi-stakeholder workshops convened by the
group ensured that the statements, derived from global and local guidelines,
and their corresponding indicators were relevant and acceptable to clinicians
and policy-makers in Kerala. Furthermore, it helped identify practical methods
for implementing the standards and monitoring outcomes.
Lessons learned: An independent evaluation of the project highlighted the
equal importance of a strong evidence-base and an inclusive development
process. There is no one-size-fits-all process for QS development; a
principle-based approach might be a better guide for countries to adapt global
evidence to their local context.
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The challenge
For low and middle-income countries (LMIC) moving towards 
Universal Health Coverage, social protection and the expansion of 
access to essential health services need to be balanced with efforts 
to ensure quality of care1. In the case of maternal health, addressing 
the “quality care gap” for births occurring in health facilities is cen-
tral to achieve the promised reductions in maternal deaths by imple-
menting the available effective and cost-effective interventions2. 
However, implementation of global clinical guidelines remains 
unsatisfactory, even in the case of basic, well established inter-
ventions3,4. In this context, there have been calls for strengthening 
the evidence base on the implementation of such interventions in 
LMIC settings, including in terms of feasibility and replicability5.
This paper describes the partnership between NICE International, 
a division of the National Institute for Health and Care Excellence 
(NICE), United Kingdom, the Government of Kerala, India, and the 
Kerala Federation of Obstetrics and Gynaecology (KFOG) in devel-
oping and implementing the first clinical quality standards (QS) for 
reducing maternal mortality in the state, based on robust clinical 
guidelines. It thus explores the complex process of developing and 
implementing evidence-based QS in a LMIC setting and, more sig-
nificantly, the difficulty of embedding QS in quality improvement 
processes within the health system.
Quality standards are a concise sets of prioritised statements 
designed to drive measurable quality improvements6. They provide 
“health policymakers, health insurers, service providers, healthcare 
professionals and patients with definitions of what high quality 
healthcare looks like in practice; and related performance measures 
that are reliable and meaningful to the local setting in which they 
are used”7. As such, the development and implementation of QS 
are highly context-specific. By presenting the process of develop-
ing and implementing QS in a LMIC context, this paper highlights 
lessons learned for similar settings, while acknowledging that the 
process cannot be simply transferred from setting to setting. In 
doing so, the paper also reflects on global health partnerships and 
on the sustainability of evidence-informed decision-making proc-
esses established through such partnerships8. Box 1 summarises the 
key messages of this paper.
Box 1. Summary points
1.   In the development of QS in LMIC contexts, local buy-in for 
the process of development as well as for the end product 
bear equal importance.
2.   There is no one-size-fits-all process for QS development - 
instead, a principle-based approach might be a better guide 
for countries to adapt global evidence to their local context.
3.   Agencies like NICE International, which provide technical 
support for evidence-informed decision-making processes, 
will maximise their effectiveness if the local demand and 
the capacity for such processes (and their products) is 
stimulated and policy makers fully engaged.
Background to the partnership
NICE International started engaging with the Indian state of Kerala 
in 2009, at the invitation of the then Minister and Principal Secre-
tary for Health, with a workshop organised by the state’s Ministry 
of Health. The workshop was designed as a multidisciplinary con-
sultation around priority areas for the Kerala Ministry of Health, 
related to quality of care: quality standards and standard operating 
procedures for hospital providers; standard treatment guidelines 
(STGs); and approaches to implementation of STGs and clinical 
pathways. What followed was an exploratory period including sev-
eral visits to NICE’s headquarters by Kerala policy-makers and 
characterised by the creation of informal networks with individuals 
in leadership positions from government bodies and professional 
organisations in Kerala. This period of informal engagement culmi-
nated in a project conceived to support the Government of Kerala in 
the development and implementation of QS for preventing maternal 
mortality, a policy priority for the state.
Although Kerala has the lowest maternal mortality rate (MMR) in 
India and has achieved the associated Millennium Development 
Goal targets9, its government had pledged to reduce it further, aim-
ing at a 50% decrease in MMR by 2017, the end of its 12th five year 
plan on medical and public health10. Table 1 outlines key indicators 
related to maternal health in Kerala, by comparison to the national 
level.
The priority given to maternal health by the Government can be 
explained by the fact that, compared to other health indicators, such 
as life expectancy and infant mortality rate, the MMR had remained 
relatively high, with no significant improvements in recent years. 
Ninety eight per cent of deliveries in Kerala take place in institu-
tions, suggesting that efforts to reduce avoidable maternal deaths 
should focus on improving care at health facilities11. Out of the over 
500 000 deliveries registered in Kerala annually, approximately 
72% take place in private facilities, and 28% in public government 
teaching and non-teaching hospitals12. The high rates of institutional 
delivery, low fertility and high female literacy suggested that reduc-
tions in avoidable maternal deaths are possible through improve-
ments in quality of care.
Table 1. Maternal health landscape in Kerala.
Kerala India
Total Population 33.4 Million 1.237 Billion
Infant Mortality Rate 12 42
Maternal Mortality Ratio* 66 190
Fertility Rate§ 1.6 2.5
Female Literacy (%) 91.98 65.4
*2010–12 Sample Registration Survey §The World Bank, 2013.
WHO, UNICEF, UNFPA, The World Bank, & UN Population Division 
Maternal Mortality Estimation Inter-Agency Group; modelled 
estimate, 2014.
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Methods
Development of quality standards in Kerala
The formal partnership between the Government of Kerala, repre-
sented by the Principal Secretary for Health and Family Welfare, 
the KFOG and NICE International was launched in 2012. It resulted 
in ten QS related to management and prevention of post-partum 
haemorrhage (PPH) (QS 1-5) and hypertension in pregnancy 
(QS 6-10). The QS were launched in January 2013, in the pres-
ence of the UK Health Minister and the Principal for Health in 
Kerala.
Local ownership was a core principle of the QS development 
process, with the Government of Kerala and KFOG taking a lead-
ership role. NICE International’s contribution was to (a) provide 
a technical and methodological framework for the development 
of the QS; (b) support the institutional partnerships between the 
Government of Kerala, the KFOG and other local stakeholders.
In terms of technical and methodological support, the NICE 
framework and processes that underpin development of QS for 
the UK National Health Service (NHS) were used. This includes 
the selection of high-priority topics for quality improvement in a 
defined service area, and combines evidence-based guidance with 
stakeholder priorities and evidence of current practices through a 
deliberative process (ran by a QS advisory committee), ultimately 
resulting in a series of quality statements and corresponding meas-
urable indicators13. For the NHS, as for the Kerala health system, 
developing QS is a highly contextualised process. As such, the 
NICE framework was adapted to fit the local context, by identify-
ing institutional decision-making rules, key stakeholders and health 
system functioning characteristics in Kerala.
Locally generated evidence played a key role, particularly in the 
identification of the leading causes of maternal death in Kerala 
and therefore the key priorities for the QS. The process was fun-
damentally informed by the Confidential Review of Maternal 
Death (CRMD) Audit, which has been run by the KFOG since 
2004 and is the only one of its kind in India11,12. As shown in 
Figure 1, PPH and hypertension are the two main causes of 
maternal mortality. Furthermore, they are estimated to consist-
ently account for between 29–44% of maternal deaths in Kerala 
between 2006–200914.
Together with the findings of the CRMD, local epidemiological 
data and routinely reported systems data (e.g., the Sample Registra-
tion System conducted by the Office of the Register General) were 
assessed using deliberative multi-stakeholder processes convened 
with mentorship from NICE International. This mentorship con-
sisted of a total of eight workshops (four during the development 
period and four during implementation). The multi-stakeholder 
workshops that comprised the QS development process functioned 
to support the creation and maintenance of institutional links, most 
notably between KFOG and the state’s Government. Following an 
initial workshop in June 2012, focused on the active management 
of the third stage of labour (one of the ten statements included in 
the first edition of the finalised standards), a multidisciplinary group 
was established to lead on the development of the standards, the 
wider consultation process for each statement, and the implementa-
tion of the QS. Members included key policy-makers (the Principal 
Secretary, the Director of the State’s National Health Mission-
NHM) and leading gynaecologists and obstetricians, nurses and 
administrators from across Kerala.
The group developed quality statements derived from evidence-
based guidelines published by the KFOG, NICE, the World Health 
Organization, and the UK Royal College of Obstetricians and 
Gynaecologists (see Box 2 for an example of a quality statement 
and its link to global guidelines), but adapted based on the experi-
ence of practising obstetricians and nurses in Kerala.
Pilot implementation of the Quality Standards
The QS implementation required action ranging from monitoring 
(antenatal and labour), to administering drugs and blood products, 
to referral procedures. These actions raised implementation needs 
related to data collection mechanisms, on the one hand, and state-
wide implementation support mechanisms, on the other. Through 
Figure 1. Main causes of maternal deaths in Kerala, 2012. Adapted from the 2nd edition of the CRMD12.
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Box 2. Example of guideline recommendations and their adaptation in the Kerala QS. Adapted from Principles for developing 
clinical quality standards in low and middle income countries (14)
Contextualization of global evidence – Global guidelines and Kerala QS for active management of third stage of labour
WHO recommendation 
•   The use of uterotonics for the prevention of PPH during the third stage of labour is recommended for all 
births.
•   Oxytocin (10 IU, IV/IM) is the recommended uterotonic drug for the prevention of PPH.
•   If intravenous oxytocin is unavailable, or if the bleeding does not respond to oxytocin, the use of 
intravenous ergometrine, oxytocin-ergometrine fixed dose, or a prostaglandin drug (including sublingual 
misoprostol, 800 μg) is recommended.
Kerala Quality Standard
Quality statement 
Women who have given birth either vaginally or by caesarean are offered a bolus dose of Oxytocin, 
Ergometrine or Protaglandin F2 Alfa at the time of delivery of the shoulder or within 1 minute of the 
delivery of foetus to prevent post-partum haemorrhage and to assist delivery of the placenta.
Definitions 
Definitions of, e.g., “third stage of labour”, “active management of third stage of labour”, “Oxytocin”.
Quality Measure 
Structure:  
a) Evidence of agreed guidelines or protocols in the hospital for the active management of the third stage 
of labour. 
b) Display of flow charts based on agreed guidelines, protocols or clinical pathways in the labour room. 
c) Evidence of availability of Oxytocin, Ergometrine and PG F2 Alfa at the place of delivery. 
d) Evidence of suitable storage facilities (refrigerator) for the drugs. 
e) Evidence of equipment for measuring blood loss. 
 
Example of process measure for vaginal deliveries:  
Proportion of women giving birth vaginally who receive the Oxytocin, 
Ergometrine or PGF2 Alfa during third stage management of labour during the month (including 
numerator/denominator indicators). 
 
Example of outcome measure for vaginal deliveries:  
Proportion of women who experience an estimated blood loss equal to or more than 500 ml during and or 
following a vaginal delivery (including numerator/denominator indicators).
Explanations of what the QS means for each audience 
Service providers, healthcare professionals, payers.
Data Sources 
Data collection needs and procedures for the monitoring of the QS implementation (e.g., labour room 
register, monthly reporting forms to the NHM).
Source Guidance 
Sources of global and local evidence used for the development of the statements and of the indicators.
the consultation processes, the multi-stakeholder group identified 
practical methods for implementing the standards and monitor-
ing outcomes. The implementation plan, including an initial needs 
assessment, identified the need for staff training, as well as for 
upfront investment in infrastructure, improvements of drug avail-
ability and the need to support clinical audit. All 400 staff working 
in the maternity wards of the pilot health facilities participated in an 
initial training carried out by the KFOG. The Government of Kerala 
allocated the funds needed to cover these needs for the pilot period, 
as per the core tasks outlined in Box 3.
Implementation pilots started in six public and two private mater-
nity hospitals across Kerala in April 2013. In line with the plan, 
pilot hospitals collected monthly data on the QS indictors from 
their delivery registers and sent them to the NHM for analysis. 
These data were discussed in monthly review meetings chaired by 
the NHM Director, where the staff from the pilot maternities, mem-
bers from the KFOG and technical staff from the NHM reviewed 
progress reports and provided feedback on the process of imple-
menting the standards. These meetings were designed to create a 
feedback loop supporting implementation.
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Results
Lessons learned
An independent, qualitative evaluation of NICE International’s engage-
ment in Kerala was conducted in order to shed light on the lessons 
learned following a year of QS implementation (2013–2014). Drawing 
on key informant interviews and a document review, the assessment 
focused on participants’ perception on the overall value of the QS, as 
well as how the staff training helped implement the QS and improve 
practice. The evaluation also examined the extent to which similar ini-
tiatives had been taken up in other locations and whether new, similar 
partnerships were developed by NICE International in India. The focus 
on perceptions about the process highlights the importance placed by 
NICE International on the local ownership of the project15.
With regards to the overall value of the QS, participants valued the 
deliberative development process as being critical in producing 
statements and indicators that were relevant and acceptable to both 
clinicians and policy-makers in Kerala. This deliberative approach, 
which participants indicated was innovative for producing QS in 
Kerala, was seen as having maximised the likelihood of implementa-
tion, especially given that the major partners in developing the QS 
were also involved in piloting. There was particular value placed on 
the fact that NICE International’s approach is non-prescriptive, thus 
allowing for the QS development and implementation to be locally 
owned and driven by Kerala institutions. It thus resulted in guid-
ance that was perceived as detailed and explicit, compared to other 
more general sources of guidance. However, despite a high buy-in 
for the implementation process, there remained a perceived tension 
between providing standardised care and professional freedom. Con-
sequently, it remains to be seen whether similar level of acceptance 
would be replicated when the QS are scaled up across Kerala, when 
it is expected that the main value of the QS would stem from their 
perceived role in improving quality of care and/or clinical outcome.
With regards to implementation, the QS were perceived as a valu-
able tool to improve and standardise quality of care, exemplified 
by changes in practice such as: the introduction of management 
of fourth stage of labour; the use of sterile delivery kits; greater 
consistency in the management of the third stage of labour and the 
use of oxytocin; the measurement of blood loss instead of subjec-
tive estimation; and better record keeping. Furthermore, staff from 
the sampled pilot maternities reported high satisfaction with the QS 
and in some cases increased confidence in PPH management when 
following the standards.
Challenges referred to insufficient staffing in some of the pilot 
hospitals, on the one hand, and variability in practice, on the 
other. Specifically, the independent evaluation suggested a lack of 
sufficient staff for managing fourth stage of labour and variations 
in some of the actions indicated by the QS, i.e., use of magnesium 
sulphate to prevent eclampsia and of urine protein testing. This 
highlights the importance of standard operating procedures for 
each facility, which need to be updated during and beyond the 
piloting phase. These standard operation procedures refer to the 
need that each facility consider the QS implementation in term 
of staff training needs, drug supply, referral systems and staff-
ing for the needed monitoring14. Furthermore, the importance 
of staff training was highlighted as key for the sustainability of 
the implementation, particularly given the observed high turno-
ver of labour room staff. Pilot data suggested that a refresher of 
the initial staff training provided by KFOG is needed in order 
to respond to the requirements of implementation and ensure its 
sustainability. Plans for ongoing training, under discussion at sev-
eral review meetings, highlighted the need to target both central 
level staff (to ensure continued support for the implementation), 
as well as clinicians and nurses (to account for staff turnover and 
as a refresher).
Box 3. Core tasks for the implementation of the QS
Orientation meeting An information meeting held by the NHM director with directors of pilot hospitals to explain the QS work.
Needs assessment of pilot hospitals
Each pilot hospital conducted an inventory of equipment, staffing and other 
components needed for the QS implementation to identify gaps in existing 
resources.
Baseline data collection forms Data collection proforma to collect retrospective baseline data on QS indicators in pilot hospitals.
Reporting form and registers - design 
and printing Redesigning existing labour registers to collect data for QS indicators.
QS document Edit, design, print and launch of the QS document.
Flow charts design and printing Posters representing the QS to be posted in labour wards.
Training 2-day training sessions for all frontline maternity staff (400) in the pilot hospitals.
Human Resources Staff redeployment needed to ensure adequate capacity to implement QS (e.g., 2-hour observation post-delivery).
Procurement Procurement of equipment, materials and drugs needed.
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Another important lesson learned stems from the lack of baseline 
data (which was discussed at the workshops, but not collected during 
implementation), as it would have allowed a quantitative assess-
ment of quality improvements. A related issue was that the compi-
lation of data in the maternity wards and the feedback loop between 
the NHM and the pilot maternities has not functioned as well as 
was expected. For example, the data recorded in the labour registers 
designed for implementing the QS were not analysed systemati-
cally in order to identify needed adjustment to the implementation. 
In addition, few facilities carried out clinical audit, which would 
have provided an opportunity for staff to reflect on their practice. 
As a result, the monthly meetings between the NHM and facilities 
identified deficiencies in monitoring improvement in the process 
of care. This highlights the need to strengthen local data analysis 
capacity, as well as ongoing staff training throughout the imple-
mentation of the QS, whether at pilot level or for scale up.
The road ahead
The Kerala experience up to this point illustrates a process of 
engagement with top-level policy-makers that built on global and 
existing local evidence and led to the implementation of QS at facil-
ity level. In recording elements of this experience, this paper provides 
an account of the process of complex decision-making informed by 
evidence in a “real life” situation in a LMIC setting, across different 
institutional levels of the health system, with international support, 
but limited international funding for implementation.
A major takeaway from this process, which is ongoing, refers to 
the importance of engaged professional and policy leaders who are 
able to promote rapid change in the community, with a high level of 
visibility and acceptability. However, there is a danger that the con-
tinuity of the process may be affected when key individuals change 
posts and responsibilities and their initial input cannot be sustained. 
NICE International’s engagement in Kerala aimed to support suffi-
ciently robust institutional links for the QS implementation process 
to continue when unavoidable changes in leadership happened. As 
a complex health system intervention, future will tell the extent to 
which this has been successful. It is encouraging that the Govern-
ment of Kerala decided to expand the implementation of the QS 
to another 32 health facilities in Kerala. Furthermore, the process 
for developing the standards has garnered interest at state level and 
across India. The Government of Kerala completed QS for neonatal 
care in 2015, recently pledging Rs. 25 crore (USD4 million) for 
their implementation in 22 hospitals as well as expressing interest 
in their applications to antenatal care. Combined staff training is 
now taking place to implement both the maternal and neonatal QS 
in these facilities.
Similarly, there are nascent plans to draw on the QS development 
processes in other Indian states and at central level. Government 
officials in other states (Bihar, Odisha), having visited Kerala and 
interacted with NICE International, have expressed interest in the 
CRMD and QS process. Furthermore, the Rashtriya Swasthya 
Bima Yojna (RSBY), the government health insurance scheme for 
population under the poverty line, commissioned the development 
of clinical pathways for seven medical conditions, using principles 
for evidence-informed decision-making that were at the core of the 
QS development process, with the goal to eliminate the practice of 
wasteful and expensive medical procedures. Further, the Ministry 
of Health and Family Welfare (MoHFW) has commissioned the 
development of twelve Standard Treatment Guidelines that include 
Quality Standards for twelve health conditions, using a similar 
framework to the one used in Kerala.
However, the independent assessment carried out by Itad15 suggests 
that some stakeholders valued the QS more as a product, rather than 
as a process that can be scaled up and replicated. This difference 
in perceptions regarding replicability highlights the importance of 
local buy-in for the principles of evidence-informed decision-mak-
ing, and not only for its products (in this case, the QS). The process 
of participative development needs to be carried out in each specific 
context. Even if the product turns out to be similar across contexts, 
local input in the process is too vital to be bypassed, especially 
with regards to the feasibility of implementation. Recognizing 
this, NICE International has developed a guide containing princi-
ples (and not a standardised process) for developing QS in LMICs, 
using examples based on the experience in Kerala and suggesting 
ways of adapting such principles to diverse local contexts7.
Global health partnerships as the one presented here, need to support 
institutionalised processes of evidence-informed decision-making 
at local level; this is critical for sustainability, especially when faced 
with unavoidable changes in leadership. While informal networks 
can initially help establish such partnerships, this desirable shift 
from informal to institutional links promotes good governance in 
global health partnerships16. Organisations like NICE International, 
which provide technical support for evidence-informed decision-
making processes, will maximise their impact if the local demand 
and the capacity for such processes (and their products) is stimu-
lated and constantly engaged.
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 Rachel Foskett-Tharby
National Collaborating Centre for Indicator Development, Primary Care Clinical Sciences, University of
Birmingham, Birmingham, UK
This is an interesting report of a quality improvement initiative which highlights the importance of such
activities being piloted and refined prior to widespread implementation. I have a couple of minor
comments:
Firstly, given that the evaluation appeared to cover the full quality standard it would be useful for
readers to be able to review the full list of QS statements. Could this be added as a table or
supplementary information?
 
Secondly, the first paragraph of the results describes the methods of the evaluation. The authors
may wish to move this to methods section and provide more detail.
 
Thirdly, it would be useful to have some more information about the participants in the evaluation
e.g. roles, participation in the development of the QS as this would provide some context for the
findings.
I have read this submission. I believe that I have an appropriate level of expertise to confirm that
it is of an acceptable scientific standard.
 I have worked with NICE International on a different quality improvement initiative.Competing Interests:
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Interesting paper addressing an important public health topic. Well written and contains methods and
models that could be replicated and implemented in different settings.
I have read this submission. I believe that I have an appropriate level of expertise to confirm that
it is of an acceptable scientific standard.
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,  Nerges Mistry Shilpa Karvande
 Director and Trustee, Foundation for Research in Community Health, Mumbai, Maharashtra, India
 Research Officer, Foundation for Research in Community Health, Pune, MH, India
The case study by Vlad  is a significant example how quality initiatives are nested within the publicet al.
health system of Kerala – a “health iconic” State of South India.
 
The representativeness of this case study for other States in India (particularly those with weak health
systems and poor socio-economic indices) is possibly quite weak and needs to have a cautionary
mention in the discussion.
 
The uniqueness of the components of the Kerala initiative need to be highlighted. In my opinion these
would comprise of (a) the significant and dedicated contribution of private participants and the KFOG in
persistently facilitating the quality initiatives yet placing it in the hands of the public health sector (b) the
wise buy in of the Government of Kerala of international evidence based initiatives and for forging a
symbiotic relationship with the private sector (e) facilitation of completion of approach through
implementation processes such as definition of quality benchmarks and facility level training.
 
It is hoped that the pioneering efforts of Kerala find wide resonance in other parts of India
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